Skip to main content
. 2011 Sep-Dec;17(3):175–178. doi: 10.4103/0971-6866.92098

Table 9.

CYP3A5*3 polymorphism and complete remission rates in all and AML groups

graphic file with name IJHG-17-175-g009.jpg